CLDX logo

Celldex Therapeutics, Inc. (CLDX) Total Assets

Annual Total Assets:

$792.34M+$326.71M(+70.17%)
December 31, 2024

Summary

  • As of today, CLDX annual total assets is $792.34 million, with the most recent change of +$326.71 million (+70.17%) on December 31, 2024.
  • During the last 3 years, CLDX annual total assets has risen by +$347.69 million (+78.19%).
  • CLDX annual total assets is now at all-time high.

Performance

CLDX Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXbalance sheet metrics

Quarterly Total Assets:

$692.41M-$47.06M(-6.36%)
June 30, 2025

Summary

  • As of today, CLDX quarterly total assets is $692.41 million, with the most recent change of -$47.06 million (-6.36%) on June 30, 2025.
  • Over the past year, CLDX quarterly total assets has dropped by -$153.18 million (-18.12%).
  • CLDX quarterly total assets is now -20.31% below its all-time high of $868.85 million, reached on March 31, 2024.

Performance

CLDX Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXbalance sheet metrics

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

CLDX Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+70.2%-18.1%
3Y3 Years+78.2%+71.8%
5Y5 Years+544.5%+164.9%

CLDX Total Assets Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+124.6%-20.3%+147.1%
5Y5-Yearat high+544.5%-20.3%+238.5%
All-TimeAll-Timeat high>+9999.0%-20.3%>+9999.0%

CLDX Total Assets History

DateAnnualQuarterly
Jun 2025
-
$692.41M(-6.4%)
Mar 2025
-
$739.47M(-6.7%)
Dec 2024
$792.34M(+70.2%)
$792.34M(-3.7%)
Sep 2024
-
$823.18M(-2.6%)
Jun 2024
-
$845.59M(-2.7%)
Mar 2024
-
$868.85M(+86.6%)
Dec 2023
$465.63M(+32.0%)
$465.63M(+66.1%)
Sep 2023
-
$280.26M(-6.4%)
Jun 2023
-
$299.31M(-7.8%)
Mar 2023
-
$324.52M(-8.0%)
Dec 2022
$352.74M(-20.7%)
$352.74M(-4.5%)
Sep 2022
-
$369.23M(-8.4%)
Jun 2022
-
$402.96M(-5.0%)
Mar 2022
-
$424.04M(-4.6%)
Dec 2021
$444.65M(+88.5%)
$444.65M(-3.4%)
Sep 2021
-
$460.20M(+125.0%)
Jun 2021
-
$204.55M(-6.6%)
Mar 2021
-
$219.06M(-7.1%)
Dec 2020
$235.84M(+91.8%)
$235.84M(-7.8%)
Sep 2020
-
$255.77M(-2.2%)
Jun 2020
-
$261.40M(+132.3%)
Mar 2020
-
$112.50M(-8.5%)
Dec 2019
$122.93M(-21.1%)
$122.93M(-6.8%)
Sep 2019
-
$131.84M(-7.3%)
Jun 2019
-
$142.24M(-3.6%)
Mar 2019
-
$147.58M(-5.3%)
Dec 2018
$155.81M(-50.6%)
$155.81M(-7.4%)
Sep 2018
-
$168.29M(-5.7%)
Jun 2018
-
$178.38M(-6.8%)
Mar 2018
-
$191.38M(-39.4%)
Dec 2017
$315.62M(-17.7%)
$315.62M(-1.2%)
Sep 2017
-
$319.42M(-7.7%)
Jun 2017
-
$346.07M(-3.9%)
Mar 2017
-
$360.05M(-6.1%)
Dec 2016
$383.36M(+13.6%)
$383.36M(+52.2%)
Sep 2016
-
$251.95M(-7.1%)
Jun 2016
-
$271.21M(-10.2%)
Mar 2016
-
$301.93M(-10.6%)
Dec 2015
$337.58M(+36.1%)
$337.58M(-4.3%)
Sep 2015
-
$352.63M(-8.0%)
Jun 2015
-
$383.22M(-6.0%)
Mar 2015
-
$407.70M(+64.4%)
Dec 2014
$248.01M(-28.5%)
$248.01M(-8.7%)
Sep 2014
-
$271.67M(-8.7%)
Jun 2014
-
$297.59M(-6.6%)
Mar 2014
-
$318.70M(-8.2%)
Dec 2013
$347.10M(+176.5%)
$347.10M(+91.8%)
Sep 2013
-
$180.96M(-7.8%)
Jun 2013
-
$196.23M(-12.5%)
Mar 2013
-
$224.37M(+78.7%)
Dec 2012
$125.54M(+28.1%)
$125.54M(+4.8%)
Sep 2012
-
$119.84M(-1.9%)
Jun 2012
-
$122.13M(-10.7%)
Mar 2012
-
$136.74M(+39.5%)
Dec 2011
$97.99M(-10.9%)
$97.99M(-9.6%)
Sep 2011
-
$108.45M(-8.5%)
Jun 2011
-
$118.48M(+28.2%)
Mar 2011
-
$92.40M(-16.0%)
Dec 2010
$109.94M(-21.7%)
$109.94M(-1.7%)
Sep 2010
-
$111.81M(-8.0%)
Jun 2010
-
$121.57M(-8.2%)
Mar 2010
-
$132.44M(-5.6%)
Dec 2009
$140.36M(+101.1%)
$140.36M(+191.8%)
Sep 2009
-
$48.10M(-11.6%)
Jun 2009
-
$54.41M(-14.3%)
Mar 2009
-
$63.48M(-9.0%)
Dec 2008
$69.79M(+85.4%)
$69.79M(-11.9%)
Sep 2008
-
$79.19M(-8.3%)
Jun 2008
-
$86.34M(+111.6%)
Mar 2008
-
$40.80M(+8.4%)
Dec 2007
$37.65M(-38.8%)
$37.65M(-38.8%)
DateAnnualQuarterly
Dec 2006
$61.48M(+68.7%)
$61.48M(-4.0%)
Sep 2006
-
$64.05M(-6.6%)
Jun 2006
-
$68.55M(-6.5%)
Mar 2006
-
$73.31M(+101.1%)
Dec 2005
$36.45M(-20.4%)
$36.45M(-9.0%)
Sep 2005
-
$40.06M(-9.9%)
Jun 2005
-
$44.48M(+10.7%)
Mar 2005
-
$40.17M(-12.3%)
Dec 2004
$45.80M(+46.3%)
$45.80M(-0.7%)
Sep 2004
-
$46.13M(-5.7%)
Jun 2004
-
$48.90M(-6.6%)
Mar 2004
-
$52.33M(+67.2%)
Dec 2003
$31.31M(-11.1%)
$31.31M(-11.0%)
Sep 2003
-
$35.17M(+22.2%)
Jun 2003
-
$28.78M(-10.1%)
Mar 2003
-
$32.02M(-9.1%)
Dec 2002
$35.23M(-34.1%)
$35.23M(-8.9%)
Sep 2002
-
$38.69M(-8.5%)
Jun 2002
-
$42.26M(-11.4%)
Mar 2002
-
$47.73M(-10.8%)
Dec 2001
$53.48M(-15.9%)
$53.48M(+14.8%)
Sep 2001
-
$46.58M(-12.7%)
Jun 2001
-
$53.34M(-8.1%)
Mar 2001
-
$58.05M(-8.7%)
Dec 2000
$63.56M(+219.7%)
$63.56M(+219.7%)
Dec 1999
$19.88M(-12.2%)
$19.88M(-15.0%)
Sep 1999
-
$23.38M(+41.7%)
Jun 1999
-
$16.50M(-16.2%)
Mar 1999
-
$19.68M(-13.1%)
Dec 1998
$22.65M(+130.5%)
$22.65M(-9.9%)
Sep 1998
-
$25.15M(+155.6%)
Jun 1998
-
$9.84M(-15.1%)
Mar 1998
-
$11.58M(+18.2%)
Dec 1997
$9.83M(-42.9%)
$9.80M(-14.8%)
Sep 1997
-
$11.50M(-14.2%)
Jun 1997
-
$13.40M(-10.7%)
Mar 1997
-
$15.00M(-12.8%)
Dec 1996
$17.22M(-7.1%)
$17.20M(-10.9%)
Sep 1996
-
$19.30M(+65.0%)
Jun 1996
-
$11.70M(-27.3%)
Mar 1996
-
$16.10M(-13.0%)
Dec 1995
$18.53M(-10.4%)
$18.50M(+58.1%)
Sep 1995
-
$11.70M(-21.5%)
Jun 1995
-
$14.90M(-17.2%)
Mar 1995
-
$18.00M(-13.0%)
Dec 1994
$20.68M(-37.5%)
$20.70M(-18.2%)
Sep 1994
-
$25.30M(-9.0%)
Jun 1994
-
$27.80M(-9.4%)
Mar 1994
-
$30.70M(-7.3%)
Dec 1993
$33.10M(+47.8%)
$33.10M(+92.4%)
Sep 1993
-
$17.20M(-10.4%)
Jun 1993
-
$19.20M(-8.6%)
Mar 1993
-
$21.00M(-13.9%)
Dec 1992
$22.40M(-17.0%)
-
Oct 1992
-
$24.40M(-5.8%)
Jul 1992
-
$25.90M(-4.1%)
Apr 1992
-
$27.00M(-3.6%)
Apr 1992
$27.00M(+104.5%)
-
Jan 1992
-
$28.00M(-1.4%)
Oct 1991
-
$28.40M(-4.7%)
Jul 1991
-
$29.80M(+125.8%)
Apr 1991
$13.20M(-15.4%)
$13.20M(+3.9%)
Jan 1991
-
$12.70M(-5.9%)
Oct 1990
-
$13.50M(-11.2%)
Jul 1990
-
$15.20M(-2.6%)
Apr 1990
$15.60M(+18.2%)
$15.60M(+32.2%)
Jan 1990
-
$11.80M(-10.6%)
Apr 1989
$13.20M(+1.5%)
$13.20M(+1.5%)
Apr 1988
$13.00M(-11.0%)
$13.00M(-11.0%)
Apr 1987
$14.60M(+356.3%)
$14.60M(+356.3%)
Apr 1986
$3.20M
$3.20M

FAQ

  • What is Celldex Therapeutics, Inc. annual total assets?
  • What is the all-time high annual total assets for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual total assets year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly total assets?
  • What is the all-time high quarterly total assets for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly total assets year-on-year change?

What is Celldex Therapeutics, Inc. annual total assets?

The current annual total assets of CLDX is $792.34M

What is the all-time high annual total assets for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual total assets is $792.34M

What is Celldex Therapeutics, Inc. annual total assets year-on-year change?

Over the past year, CLDX annual total assets has changed by +$326.71M (+70.17%)

What is Celldex Therapeutics, Inc. quarterly total assets?

The current quarterly total assets of CLDX is $692.41M

What is the all-time high quarterly total assets for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly total assets is $868.85M

What is Celldex Therapeutics, Inc. quarterly total assets year-on-year change?

Over the past year, CLDX quarterly total assets has changed by -$153.18M (-18.12%)
On this page